Related Experiment Video
Updated: Jan 18, 2026

07:22
Measuring the Motor Aspect of Cancer-Related Fatigue using a Handheld Dynamometer
Published on: February 20, 2020
6.2K
Variation in Repeated Handgrip Strength Testing Indicates Submaximal Force Production in Patients With Myalgic
1Department of Neurology and Center for Translational and Behavioral Neurosciences, University Medicine Essen, University of Duisburg-Essen, Essen, Germany.
European Journal of Neurology
|September 9, 2025
Summary
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) patients show higher handgrip strength variation than controls, suggesting motor control issues, not just peripheral dysfunction. This challenges grip strength as a sole biomarker for ME/CFS.
Area of Science:
- Neurology
- Biomarkers
- Chronic Fatigue Research
Background:
- Handgrip strength is proposed as a biomarker for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).
- This assumes peripheral neuromuscular dysfunction in ME/CFS.
- An alternative hypothesis suggests higher-order motor control alterations contribute to weakness.
Purpose of the Study:
- To analyze handgrip strength variation in ME/CFS patients and healthy controls.
- To investigate if altered motor control, rather than peripheral dysfunction, explains strength deficits in ME/CFS.
Main Methods:
- Post hoc analysis of serial handgrip strength measurements from 105 ME/CFS patients and 66 controls.
- Comparison of coefficient of variation (CV) in handgrip exertion.
- Subgroup analysis of participants with normal fatigability indexes.
Main Results:
- ME/CFS patients exhibited significantly higher CV compared to healthy controls.
- Elevated CV persisted in female ME/CFS patients even with normal fatigability.
- No significant difference in CV was found for male ME/CFS patients with normal fatigability.
Conclusions:
- Increased handgrip strength variation in ME/CFS suggests involvement of higher-order motor control deficits.
- This finding challenges the use of grip strength as a biomarker for peripheral dysfunction in ME/CFS.
- Functional weakness may stem from reduced self-efficacy within a context of chronic dysregulation.
Related Concept Videos
Myasthenia Gravis: Diagnostic Tests
1.9K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.9K
Disorders of the Skeletal Muscle
1.7K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.7K

